Profile data is unavailable for this security.
About the company
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
- Revenue in USD (TTM)16.31bn
- Net income in USD1.36bn
- Incorporated2016
- Employees91.00k
- LocationIQVIA Holdings Inc2400 ELLIS ROADDURHAM 27703United StatesUSA
- Phone+1 (919) 998-2000
- Fax+1 (302) 636-5454
- Websitehttps://ir.iqvia.com/
Mergers & acquisitions
| Acquired company | IQV:NYQ since announced | Transaction value |
|---|---|---|
| Cedar Gate Technologies LLC | -15.94% | 750.00m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revolution Medicines Inc | 0.00 | -960.98m | 18.94bn | 809.00 | -- | 11.64 | -- | -- | -5.18 | -5.18 | 0.00 | 8.42 | 0.00 | -- | -- | 0.00 | -47.87 | -28.38 | -52.53 | -30.68 | -- | -- | -- | -1,324.37 | -- | -- | 0.1384 | -- | -100.00 | -- | -37.52 | -- | 31.83 | -- |
| Exact Sciences Corp | 3.08bn | -986.58m | 19.74bn | 6.90k | -- | 7.83 | -- | 6.40 | -5.32 | -5.32 | 16.43 | 13.20 | 0.4873 | 6.67 | 10.80 | 446,671.40 | -15.60 | -11.29 | -17.40 | -12.38 | 67.37 | 71.21 | -32.01 | -30.90 | 2.44 | -- | 0.4833 | -- | 10.37 | 25.78 | -403.97 | -- | 0.9474 | -- |
| Iqvia Holdings Inc | 16.31bn | 1.36bn | 30.05bn | 91.00k | 22.55 | 4.62 | 12.10 | 1.84 | 7.86 | 7.86 | 93.98 | 38.34 | 0.5739 | -- | 4.94 | -- | 4.71 | 4.69 | 6.47 | 6.14 | 33.29 | 34.29 | 8.21 | 8.18 | -- | 3.36 | 0.7034 | -- | 5.87 | 7.50 | -0.9468 | 37.27 | -0.4257 | -- |
| Insmed Inc | 447.02m | -1.18bn | 31.66bn | 1.27k | -- | 33.37 | -- | 70.82 | -6.18 | -6.18 | 2.35 | 4.45 | 0.2026 | 0.9558 | 8.31 | 351,708.90 | -53.64 | -44.83 | -63.35 | -51.79 | 76.54 | 77.08 | -264.83 | -226.78 | 4.34 | -44.87 | 0.4351 | -- | 19.17 | 21.66 | -21.91 | -- | -12.30 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 17.98m | 10.56% |
| Harris Associates LPas of 30 Sep 2025 | 11.39m | 6.69% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 9.44m | 5.54% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 7.55m | 4.43% |
| GIC Pte Ltd. (Investment Management)as of 31 Mar 2025 | 6.54m | 3.84% |
| Geode Capital Management LLCas of 30 Sep 2025 | 4.35m | 2.56% |
| Canada Pension Plan Investment Boardas of 30 Sep 2025 | 4.12m | 2.42% |
| AllianceBernstein LPas of 30 Sep 2025 | 3.60m | 2.11% |
| Boston Partners Global Investors, Inc.as of 30 Sep 2025 | 3.56m | 2.09% |
| Artisan Partners LPas of 30 Sep 2025 | 3.43m | 2.02% |
